INS and metabolic dysfunction-associated steatotic liver disease: In addition to improving hepatic insulin sensitivity, low myostatin plasma levels reduce the expression of tumor necrosis factor α (TNFα), a factor involved in the progression of NAFLD to NASH through the induction of hepatic inflammation [60,61].